Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Proteomics signature profiling (PSP): a novel contextualization approach for cancer proteomics.

Goh WW, Lee YH, Ramdzan ZM, Sergot MJ, Chung M, Wong L.

J Proteome Res. 2012 Mar 2;11(3):1571-81. doi: 10.1021/pr200698c. Epub 2012 Feb 9.

2.
3.

Network-based pipeline for analyzing MS data: an application toward liver cancer.

Goh WW, Lee YH, Zubaidah RM, Jin J, Dong D, Lin Q, Chung MC, Wong L.

J Proteome Res. 2011 May 6;10(5):2261-72. doi: 10.1021/pr1010845. Epub 2011 Mar 28.

4.

A network-based maximum link approach towards MS identifies potentially important roles for undetected ARRB1/2 and ACTB in liver cancer progression.

Goh WW, Lee YH, Ramdzan ZM, Chung MC, Wong L, Sergot MJ.

Int J Bioinform Res Appl. 2012;8(3-4):155-70. doi: 10.1504/IJBRA.2012.048967.

5.

Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.

Li N, Long Y, Fan X, Liu H, Li C, Chen L, Wang Z.

J Exp Clin Cancer Res. 2009 Aug 28;28:122. doi: 10.1186/1756-9966-28-122.

6.

Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma.

Yang L, Rong W, Xiao T, Zhang Y, Xu B, Liu Y, Wang L, Wu F, Qi J, Zhao X, Wang H, Han N, Guo S, Wu J, Gao Y, Cheng S.

Sci China Life Sci. 2013 Jul;56(7):638-46. doi: 10.1007/s11427-013-4497-x. Epub 2013 Jun 8.

PMID:
23749381
7.

Enhanced peptide quantification using spectral count clustering and cluster abundance.

Lee S, Kwon MS, Lee HJ, Paik YK, Tang H, Lee JK, Park T.

BMC Bioinformatics. 2011 Oct 28;12:423. doi: 10.1186/1471-2105-12-423.

8.

Significant correlation between expression level of HSP gp96 and progression of hepatitis B virus induced diseases.

Zhu XD, Li CL, Lang ZW, Gao GF, Tien P.

World J Gastroenterol. 2004 Apr 15;10(8):1141-5.

9.

Hepatitis B virus X protein co-activates pregnane X receptor to induce the cytochrome P450 3A4 enzyme, a potential implication in hepatocarcinogenesis.

Niu Y, Wu Z, Shen Q, Song J, Luo Q, You H, Shi G, Qin W.

Dig Liver Dis. 2013 Dec;45(12):1041-8. doi: 10.1016/j.dld.2013.06.004. Epub 2013 Jul 26.

PMID:
23891548
10.

Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.

Wei D, Zeng Y, Xing X, Liu H, Lin M, Han X, Liu X, Liu J.

J Proteome Res. 2016 Feb 5;15(2):487-98. doi: 10.1021/acs.jproteome.5b00838. Epub 2016 Jan 14.

PMID:
26709725
11.

King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.

Pang Q, Bi JB, Xu XS, Liu SS, Zhang JY, Zhou YY, Qu K, Liu C.

Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1337-46. doi: 10.1097/MEG.0000000000000452.

PMID:
26275082
12.

Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers.

Liu CC, Wang YH, Chuang EY, Tsai MH, Chuang YH, Lin CL, Liu CJ, Hsiao BY, Lin SM, Liu LY, Yu MW.

Mol Carcinog. 2014 Jan;53(1):58-66. doi: 10.1002/mc.21952. Epub 2012 Aug 21.

PMID:
22911910
13.

New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.

Göbel T, Vorderwülbecke S, Hauck K, Fey H, Häussinger D, Erhardt A.

World J Gastroenterol. 2006 Dec 21;12(47):7604-12.

14.

Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.

El-Aneed A, Banoub J.

Anticancer Res. 2006 Sep-Oct;26(5A):3293-300. Review.

15.

Occurrence of c-kit+ tumor cells in hepatitis B virus-associated hepatocellular carcinoma.

Lee ES, Han EM, Kim YS, Shin BK, Kim CH, Kim HK, Won NH, Yeom BW, Kim I, Leong AS.

Am J Clin Pathol. 2005 Jul;124(1):31-6.

PMID:
15923163
16.

Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.

Mas VR, Maluf DG, Archer KJ, Yanek K, Bornstein K, Fisher RA.

Transplantation. 2009 Jan 15;87(1):143-52. doi: 10.1097/TP.0b013e318191c68d.

17.

Selection of reference genes for RT-qPCR analysis in tumor tissues from male hepatocellular carcinoma patients with hepatitis B infection and cirrhosis.

Liu S, Zhu P, Zhang L, Ding S, Zheng S, Wang Y, Lu F.

Cancer Biomark. 2013;13(5):345-9. doi: 10.3233/CBM-130365.

PMID:
24440974
18.

Proteomics in the study of liver pathology.

Parent R, Beretta L.

J Hepatol. 2005 Jul;43(1):177-83. Epub 2005 Apr 26. Review. No abstract available.

PMID:
15894398
19.

[Expression of MCP/CCR2 in patients of hepatocellular carcinoma and liver cirrhosis].

Fang N, Fan X, Zhang XS.

Zhonghua Gan Zang Bing Za Zhi. 2009 Jul;17(7):553-4. Chinese. No abstract available.

PMID:
19912695
20.

A novel approach for clustering proteomics data using Bayesian fast Fourier transform.

Bensmail H, Golek J, Moody MM, Semmes JO, Haoudi A.

Bioinformatics. 2005 May 15;21(10):2210-24. Epub 2005 Mar 15.

PMID:
15769836

Supplemental Content

Support Center